Typhoid Vi Polysaccharide Vaccine (Typhim Vi)
Typhoid Vi Polysaccharide Vaccine is an FDA-licensed reference biologic from Sanofi Winthrop Industrie. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2000
Reference approved
Reference product
Typhim Vi Typhoid Vi Polysaccharide Vaccine
Sanofi Winthrop Industrie
- Approved
- Feb 04, 2000
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Typhoid Vi Polysaccharide Vaccine, in chronological order.
Reference approval
Approval date of the reference Typhoid Vi Polysaccharide Vaccine product.
26 yr 8 mo ago
Frequently asked questions
Are there biosimilars approved for Typhoid Vi Polysaccharide Vaccine (Typhim Vi)?
No 351(k) biosimilars or interchangeable biosimilars referencing Typhoid Vi Polysaccharide Vaccine are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.